Beyond Calcium Scoring: How AI-Driven Plaque Analysis is Redefining Coronary Care
In this expert exchange, Drs. Michael Gibson and Allen Taylor explore a fundamental shift in coronary care: moving beyond traditional risk scores toward a disease-based understanding of coronary artery disease.
“It’s time to get a smartphone and leave your flip phone behind; we’ve got to move into this era because we have the therapies and we have the tools now.” — Dr. Allen Taylor
Dr. Gibson and Dr. Taylor highlight how the integration of CCTA with AI-driven plaque analysis is advancing clinician understanding beyond the limitations of calcium scoring alone. While calcium scores capture calcified burden, they can overlook non-calcified “vulnerable” plaque that contributes meaningfully to ischemia and adverse cardiac events.1
By quantifying total plaque volume and composition, physicians can more precisely characterize coronary artery disease (CAD) and assess its severity, similar to how an oncologist stages cancer, transitioning guesswork to a definitive anatomical and physiological understanding.
Together, these perspectives reflect a broader shift toward evaluating CAD as a measurable, stageable condition that can be assessed anatomically and physiologically over time to support more informed clinical decisions.2
See CAD. Manage for life.
